Mayne Pharma Group Ltd

MYX

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    http://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    30 June 2025

    Employees

    160

Mayne Pharma Group Ltd News & Analysis

stocks

Mayne Pharma woes to persist for 2020

Morningstar had forecast big losses for the drugmaker, which has been dropped from the ASX 200.
stocks

How the Morningstar Best Ideas list did in 2019

We put our best stock ideas under the microscope.
stocks

Scott and Josh take note: our strategic assets are off limits

A successful bid for APA would relinquish key energy assets forever and funnel profits to China and Hong Kong - a tragedy in the making that Canberra must avert.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,410.7094.001.13%
CAC 407,274.4819.89-0.27%
DAX 4019,884.7585.11-0.43%
Dow JONES (US)42,840.26498.021.18%
FTSE 1008,084.6120.71-0.26%
HKSE19,778.3757.670.29%
NASDAQ19,572.60199.831.03%
Nikkei 22539,033.16331.260.86%
NZX 50 Index12,912.948.830.07%
S&P 5005,930.8563.771.09%
S&P/ASX 2008,159.7092.701.15%
SSE Composite Index3,363.214.86-0.14%

Market Movers